Physician profile
Mathew Roy
NPI 1801243779
$906.97
in general payments reported to CMS, 2019-2025
10 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $137 · 2022: $454 · 2023: $184 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $315.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $228.26 | 2021-2022 | |
| Novo Nordisk INC | $158.20 | 2022-2025 | Ozempic, Rybelsus |
| Halozyme INC | $138.47 | 2023 | |
| Inspire Medical Systems, INC. | $119.04 | 2022 | |
| Viiv Healthcare Company | $107.49 | 2022-2023 | Apretude |
| Antares Pharma, INC. | $54.58 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Lilly USA, LLC | $38.22 | 2025 | Zepbound, Mounjaro |
| Abbott Laboratories | $24.18 | 2025 | Eterna |
| Exact Sciences Corporation | $23.58 | 2025 | The Cologuard Plus Collection Kit |
| Becton, Dickinson and Company | $14.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mathew Roy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.